Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (199)	1/14/2003 3:54:25 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

INGN Is still up 35.33% as the volume is now past the 312K (about 19x its daily average) The move started with a small up-gap this morning and increased its momentum and up-volume after 1PM ET when it was mentioned the results of ADVEXIN combined with radiation in the Phase 2 trial on non-small cell lung Ca, which showed that approximately 60% of patients' primary tumors regressed or disappeared and there was no significant added toxicity. Message 18443071 siliconinvestor.com Bernard